Examining Genetic Ancestry, Allostatic Load and Treatment Completion among Patients with Breast Cancer
T
Tarah Ballinger, MD
Primary Investigator
Enrolling By Invitation
18-100 years
Female
Phase
N/A
3 participants needed
4 Locations
Brief description of study
What is the purpose of this study?
The main purpose of this study is to learn more about how genetic ancestry affects treatment completion for patients who are diagnosed with breast cancer.
THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic.
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office
Email: iutrials@iu.edu
Phone: (317) 278-5632
Detailed description of study
What will happen during the study?
- This study is a multi-institutional prospective observational cohort study of newly diagnosed self-reported Black and White women with stages I-III breast cancer patients aged ≥18.
- At study entry, baseline information on sociodemographic factors, clinical factors, AL biomarkers and patient reported outcomes will be collected.
- Patients will complete required surveys and will be recruited over a 3-year period at OSUCCC, IU Health and MetroHealth.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Breast Cancer
-
Age: Between 18 Years - 100 Years
-
Gender: Female
Inclusion Criteria:
- Newly diagnosed yet untreated self-reported Non-Hispanic Black, Non-Hispanic White, Hispanic-Black, and Hispanic White patients with breast cancer, regardless of performance status ages ≥18 with clinical stages I-III breast cancer at diagnosis
- Scheduled to receive chemotherapy and/or radiation therapy at any of the OSUCCC, IU Health or MetroHealth System locations
- Patient can provide written informed consent
- Fluent in English (for completion of study measures)
- No prior cancer diagnosis or systemic therapy or radiation therapy.
Exclusion Criteria:
- Incarcerated individuals
- Men
- Individuals not able to speak and understand English
- Known personal history of ductal carcinoma in situ (DCIS) or invasive breast cancer
- Stage IV breast cancer
- Women identifying as American Indian, Alaskan Native, Asian, Native Hawaiian or Other Pacific Islander will be excluded
Updated on
01 Aug 2024.
Study ID: CTO-2022C0174, 18805
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
